Macrolides containing pharmaceutical compositions

Details for Australian Patent Application No. 2002346859 (hide)

Owner Novartis AG

Inventors Meingassner, Josef Gottfried

Agent Davies Collison Cave

Pub. Number AU-B-2002346859

PCT Number PCT/EP02/11799

PCT Pub. Number WO2003/035068

Priority 0127341.6 14.11.01 GB; 0125443.2 23.10.01 GB

Filing date 22 October 2002

Wipo publication date 6 May 2003

Acceptance publication date 2 March 2006

International Classifications

A61K 31/436 (2006.01)

A61K 31/133 (2006.01) - having hydroxy groups, e.g. sphingosine

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 0127341.6 14.11.01 GB; 0125443.2 23.10.01 GB

3 July 2003 Application Open to Public Inspection

  Published as AU-B-2002346859

2 March 2006 Application Accepted

  Published as AU-B-2002346859

3 August 2006 Standard Patent Sealed

28 February 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 12 Feb 2008. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

10 July 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Feb 2008 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346860-PHARMACEUTICAL CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-ME THYL-PROPYL)PHENOL AND PROVIDING DELAYED RELEASE OF THE ACTIVE INGREDIENT

2002346858-VACUUM PUMP